Ashigarakami-gun, Japan

Takehiro Yamane

USPTO Granted Patents = 5 


Average Co-Inventor Count = 10.0

ph-index = 3

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Takehiro Yamane: Innovator in Pharmaceutical Compounds

Introduction

Takehiro Yamane is a notable inventor based in Ashigarakami-gun, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antiviral properties. With a total of 5 patents to his name, Yamane continues to push the boundaries of innovation in drug efficacy.

Latest Patents

Yamane's latest patents include a cyclobutyl purine derivative or salt thereof, which aims to provide a compound exhibiting excellent drug efficacy as an anti-adenoviral agent. This invention is crucial in the ongoing fight against adenoviral infections. Another significant patent involves a synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, which serves as an intermediate for producing thionucleosides. The production method outlined in this patent is essential for advancing the synthesis of these important compounds.

Career Highlights

Yamane is currently employed at Fujifilm Corporation, where he applies his expertise in pharmaceutical research and development. His work has been instrumental in creating innovative solutions that address pressing health challenges.

Collaborations

Yamane collaborates with talented individuals such as Kouki Nakamura and Satoshi Shimamura. Together, they contribute to the advancement of pharmaceutical technologies and the development of new therapeutic agents.

Conclusion

Takehiro Yamane's contributions to the field of pharmaceuticals highlight his dedication to innovation and improving drug efficacy. His work continues to inspire future advancements in antiviral therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…